JPH0326194B2 - - Google Patents

Info

Publication number
JPH0326194B2
JPH0326194B2 JP4781383A JP4781383A JPH0326194B2 JP H0326194 B2 JPH0326194 B2 JP H0326194B2 JP 4781383 A JP4781383 A JP 4781383A JP 4781383 A JP4781383 A JP 4781383A JP H0326194 B2 JPH0326194 B2 JP H0326194B2
Authority
JP
Japan
Prior art keywords
carboxamide
ribofuranosyl
selenazole
acyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP4781383A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58213765A (ja
Inventor
Kenisu Robinsu Roorando
Chandora Suriuasutoa Puremu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham Young University
Original Assignee
Brigham Young University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham Young University filed Critical Brigham Young University
Publication of JPS58213765A publication Critical patent/JPS58213765A/ja
Publication of JPH0326194B2 publication Critical patent/JPH0326194B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP4781383A 1982-03-23 1983-03-22 新規な２−β−Ｄ−リボフラノシルセレナゾ−ル−４−カルボキサミド化合物およびそれらの製造方法 Granted JPS58213765A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36096882A 1982-03-23 1982-03-23
US465221 1983-02-15
US360968 1989-06-02

Publications (2)

Publication Number Publication Date
JPS58213765A JPS58213765A (ja) 1983-12-12
JPH0326194B2 true JPH0326194B2 (fr) 1991-04-10

Family

ID=23420119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4781383A Granted JPS58213765A (ja) 1982-03-23 1983-03-22 新規な２−β−Ｄ−リボフラノシルセレナゾ−ル−４−カルボキサミド化合物およびそれらの製造方法

Country Status (2)

Country Link
JP (1) JPS58213765A (fr)
ZA (1) ZA832003B (fr)

Also Published As

Publication number Publication date
ZA832003B (en) 1983-11-30
JPS58213765A (ja) 1983-12-12

Similar Documents

Publication Publication Date Title
CA2155673C (fr) Analogues d'atp n-alkyles-2-substitues
OA12384A (en) 3'-Prodrugs of 2'-deoxy-beta-l-nucleosides.
JPH0780898B2 (ja) 抗ウイルスヌクレオシド
JP2002537263A (ja) 化学物質
EP3730508A1 (fr) Composé de phosphate cyclique nucléosidique de promédicament de gemcitabine basé sur une administration hépatique spécifique, et utilisation associée
EP3820879B1 (fr) Promédicaments de gemcitabine contenant du phosphore
JP2017057200A (ja) 抗ｄｎａウィルス活性などの生理活性を有するヌクレオシド誘導体
EP0089678B1 (fr) Dérivés de 2-béta-D-ribofuranosylsélénazole-4-carboxamide et méthodes pour leur production
EP0227844B1 (fr) Medicament antiviral
JPH0326194B2 (fr)
US4594414A (en) 2-β-D-ribofuranosylselenazole-4-carboxamide compounds and methods for their production
US4594416A (en) 2-β-D-ribofuranosylselenazole-4-carboxamide compounds and methods for their production
EP0445258B1 (fr) 5'-alkylphosphonylnucleosides comme agents antiviraux
EP0054432B1 (fr) Utilisation de 2-Bêta-D-ribofuranosylthiazole-4-carboxamides pour l'obtension d'un medicament destiné pour la traitement de tumeurs malignes
JP2004525136A5 (fr)
WO1991006555A1 (fr) Derive nucleosidique
JP2004525136A (ja) イノシン化合物及び炎症性疾患もしくは再灌流疾患の治療又は予防のためのその使用
US5374626A (en) 5'-alkylphosphonylnucleosides as antivirals
JP2665527B2 (ja) ２’−デオキシ−２’−メチリデンピリミジンヌクレオチド化合物
US4680285A (en) Treatment of malignant tumors with 2-(β-D-ribofuranosylthiazole-4-carboxamide related compounds
CN109956985A (zh) 肝递送阿糖胞苷前体药物核苷环磷酸酯化合物及应用
JPH0427965B2 (fr)
JPH0340038B2 (fr)
JPH0613546B2 (ja) 核酸誘導体および該誘導体を有効成分とする制癌剤
WO1993000351A1 (fr) Nouveaux composes antiviraux et procede de preparation de composes antiviraux